195 related articles for article (PubMed ID: 31483093)
1. Synthesis, antiproliferative activity, and molecular docking studies of 4-chlorothiocolchicine analogues.
Klejborowska G; Moshari M; Maj E; Majcher U; Preto J; Wietrzyk J; Tuszynski JA; Huczyński A
Chem Biol Drug Des; 2020 Jan; 95(1):182-191. PubMed ID: 31483093
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and molecular docking studies of new amides of 4-chlorothiocolchicine as anticancer agents.
Klejborowska G; Urbaniak A; Maj E; Preto J; Moshari M; Wietrzyk J; Tuszynski JA; Chambers TC; Huczyński A
Bioorg Chem; 2020 Apr; 97():103664. PubMed ID: 32106039
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes.
Majcher U; Urbaniak A; Maj E; Moshari M; Delgado M; Wietrzyk J; Bartl F; Chambers TC; Tuszynski JA; Huczyński A
Bioorg Chem; 2018 Dec; 81():553-566. PubMed ID: 30248507
[TBL] [Abstract][Full Text] [Related]
4. New Series of Double-Modified Colchicine Derivatives: Synthesis, Cytotoxic Effect and Molecular Docking.
Krzywik J; Aminpour M; Maj E; Mozga W; Wietrzyk J; Tuszyński JA; Huczyński A
Molecules; 2020 Aug; 25(15):. PubMed ID: 32748887
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular docking studies of new amides of 4-bromothiocolchicine as anticancer agents.
Klejborowska G; Urbaniak A; Preto J; Maj E; Moshari M; Wietrzyk J; Tuszynski JA; Chambers TC; Huczyński A
Bioorg Med Chem; 2019 Dec; 27(23):115144. PubMed ID: 31653441
[TBL] [Abstract][Full Text] [Related]
6. An insight into the anticancer potential of carbamates and thiocarbamates of 10-demethoxy-10-methylaminocolchicine.
Krzywik J; Aminpour M; Janczak J; Maj E; Moshari M; Mozga W; Wietrzyk J; Tuszyński JA; Huczyński A
Eur J Med Chem; 2021 Apr; 215():113282. PubMed ID: 33611191
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Antiproliferative Activity and Molecular Docking Studies of Novel Doubly Modified Colchicine Amides and Sulfonamides as Anticancer Agents.
Krzywik J; Mozga W; Aminpour M; Janczak J; Maj E; Wietrzyk J; Tuszyński JA; Huczyński A
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295119
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, anticancer activity and molecular docking studies of N-deacetylthiocolchicine and 4-iodo-N-deacetylthiocolchicine derivatives.
Klejborowska G; Urbaniak A; Maj E; Wietrzyk J; Moshari M; Preto J; Tuszynski JA; Chambers TC; Huczyński A
Bioorg Med Chem; 2021 Feb; 32():116014. PubMed ID: 33465696
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents.
Majcher U; Klejborowska G; Kaik M; Maj E; Wietrzyk J; Moshari M; Preto J; Tuszynski JA; Huczyński A
Cells; 2018 Nov; 7(11):. PubMed ID: 30463236
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antiproliferative activity and molecular docking of Colchicine derivatives.
Huczyński A; Majcher U; Maj E; Wietrzyk J; Janczak J; Moshari M; Tuszynski JA; Bartl F
Bioorg Chem; 2016 Feb; 64():103-12. PubMed ID: 26794327
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of colchicine glycoconjugates as tubulin polymerization inhibitors.
Wang Z; Liu R; Zhang X; Chang X; Gao M; Zhang S; Guan Q; Sun J; Zuo D; Zhang W
Bioorg Med Chem; 2022 Mar; 58():116671. PubMed ID: 35193066
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors.
Sardaru MC; Craciun AM; Al Matarneh CM; Sandu IA; Amarandi RM; Popovici L; Ciobanu CI; Peptanariu D; Pinteala M; Mangalagiu II; Danac R
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1581-1595. PubMed ID: 32752898
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
14. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
[TBL] [Abstract][Full Text] [Related]
15. Discovery of dihydrofuranoallocolchicinoids - Highly potent antimitotic agents with low acute toxicity.
Shchegravina ES; Svirshchevskaya EV; Combes S; Allegro D; Barbier P; Gigant B; Varela PF; Gavryushin AE; Kobanova DA; Shchekotikhin AE; Fedorov AY
Eur J Med Chem; 2020 Dec; 207():112724. PubMed ID: 32827941
[TBL] [Abstract][Full Text] [Related]
16. Tubulin inhibitory activity of a novel colchicine-binding compounds based on a dinaphthospiropyranran scaffold.
Sundriyal S; Eeda V; Lagisetty P; Awasthi V
Bioorg Med Chem; 2021 Jan; 29():115874. PubMed ID: 33223461
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of flexible and rigid analogs of 4H-1,2,4-triazoles bearing 3,4,5-trimethoxyphenyl moiety as new antiproliferative agents.
Ansari M; Shokrzadeh M; Karima S; Rajaei S; Hashemi SM; Mirzaei H; Fallah M; Emami S
Bioorg Chem; 2019 Dec; 93():103300. PubMed ID: 31586708
[TBL] [Abstract][Full Text] [Related]
18. Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker.
Maklad RM; AbdelHafez EMN; Abdelhamid D; Aly OM
Bioorg Chem; 2020 Jun; 99():103767. PubMed ID: 32325332
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antiproliferative and antibacterial evaluation of C-ring modified colchicine analogues.
Huczyński A; Rutkowski J; Popiel K; Maj E; Wietrzyk J; Stefańska J; Majcher U; Bartl F
Eur J Med Chem; 2015 Jan; 90():296-301. PubMed ID: 25437616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
